Cadrenal Therapeutics CVKD
NASDAQ CVKD
$0.95 -0.02 (-2.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cadrenal Therapeutics (CVKD) EPS (Diluted) (2022 - 2026)

Updated

Cadrenal Therapeutics (CVKD) recorded EPS (Diluted) of -$1.14 in Q2 2026, compared with -$1.87 a year earlier.

Analysis

Cadrenal Therapeutics (CVKD) EPS (Diluted) (2022 - 2026) Analysis & Trends

On a TTM basis, Cadrenal Therapeutics' EPS (Diluted) came in at -$4.05 as of Jun 30, 2026; for FY2023, it was -$9.29.

  • Across earlier years, EPS (Diluted) came in at -$12.76 in FY2022.
  • The Q2 2026 figure is the highest quarterly EPS (Diluted) since Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 7.94
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 2.27
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 2.04
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -0.54
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 1.67
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 1.85
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 4.37
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -8.44
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -0.04
10 Cadrenal Therapeutics 3.01 Mn -9.61 Mn - -1.14
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.14
Jun 30, 2025 -1.87
Sep 30, 2024 -2.18
Jun 30, 2024 -2.24
Mar 31, 2024 -1.56
Dec 31, 2023 -1.27
Sep 30, 2023 -1.01
Jun 30, 2023 -1.28
Mar 31, 2023 -7.20
Dec 31, 2022 -9.52
Sep 30, 2022 -1.91
Jun 30, 2022 -0.95
Mar 31, 2022 -0.35
API Access

Cadrenal Therapeutics EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=CVKD&period=max&api_key=YOUR_API_KEY